Böblingen, July 21, 2025 – The renowned business magazine Markt und Mittelstand has ranked Wörwag Pharma GmbH & Co. KG at number 15 in its current 2025 ranking of the most successful medium-sized pharmaceutical companies in Germany. The ranking is based on economic indicators such as revenue, number of employees, as well as innovation strength and entrepreneurial development.
Wörwag Pharma among the Top 20 Medium-Sized Pharmaceutical Companies in Germany
From left: Jochen Schlindwein (CEO & Managing Director), Gerhard Mayer (CFO & Managing Director)
“This award is a strong signal - for our team, our customers, and partners. It confirms that we have successfully positioned ourselves as a sustainable and future-oriented medium-sized pharmaceutical company,” says Gerhard Mayer, CFO and Managing Director.
With continuous growth, investments in research and development, and a consistent customer focus, Wörwag Pharma has been able to hold its ground in a dynamic competitive environment. Being placed among the top 20 highlights the company as one of the most significant players in the German medium-sized pharmaceutical sector.
The Markt und Mittelstand ranking is published annually and evaluates medium-sized companies from various industries based on publicly available data and qualitative analyses.
“Our goal is to remain a leader in the field of biofactors and to continue using and developing them for innovative therapies. We are proud to take responsibility for health and society as a medium-sized company - both regionally and internationally,” adds Jochen Schlindwein, CEO and Managing Director.
For more information about the ranking, please visit:
Germany’s Best Medium-Sized Companies 2025